期刊文献+

免疫性血小板减少性紫癜脾切除血液学疗效与脾脏细胞免疫异常的关系 被引量:5

Relationship between the hematological outcomes of splenectomy and the abnormal cellular immunity of spleen in immune thrombocytopenic purpura
原文传递
导出
摘要 目的探讨免疫性血小板减少性紫癜(ITP)脾切除血液学疗效与脾脏细胞免疫的关系。方法应用免疫组织化学技术,采用抗人CD3、CD4、CD8单克隆抗体和抗人S100多克隆抗体,分别检测33例脾切除有效(A组)和14例脾切除无效(B组)的ITP患者的脾脏组织标本CD3+细胞、CD4+细胞、CD8+细胞和S100+细胞的表达情况,对照组为12例因外伤性脾破裂行脾切除术的脾脏组织标本(C组)。显微镜下观察脾脏组织动脉周围淋巴鞘(PALS)中染色阳性细胞的百分数,并计算CD4+/CD8+比值。分析3组CD3+、CD4+、CD8+、S100+细胞百分数和CD4+/CD8+细胞比值的差异。结果 3组PALS中CD3+、CD4+细胞百分数差异均无统计学意义;A组CD8+细胞百分数高于B组(P=0.001)和C组(P<0.01),而C组PALS中CD4+/CD8+比值分别高于A组(P=0.001)和B组(P=0.001);A组PALS中S100+细胞百分数高于B组(P=0.015)。结论 ITP患者脾脏细胞免疫存在异常。脾切除血液学疗效与脾脏细胞免疫异常有密切关系。 Objective To investigate the relationship between the hematological outcomes of splenectomy and the abnormal cellular immunity of the spleen in patients with immune thrombocytopenic purpura (ITP).Methods With the monoclonal antibody of the anti-human CD3,CD4,CD8 and the polyclonal antibody of the anti-human S100,the expression of the CD3+,CD4+,CD8+ and S100+cell in the specimens of the spleen tissue were detected by the immuohistochemistry method from 33 ITP patients who had response to splenectomy (group A) and 14 cases who had no response to splenectomy (group B).The specimens of the spleen tissue of 12 cases who underwent emergency splenectomy for traumatic rupture of spleen was served as the control group (group C).The percentages of the positive staining cells around the periarterial lymphatic sheath (PALS) of the spleen were counted under the microscope.The ratio of the percentage of CD4+cell and CD8+cell was calculated.The differences in the percentages of CD3,CD4,CD8 and S100 positive staining cells,as well as CD4+/CD8+ ratio,were analyzed among the three groups.Results No significant difference of the percentage of CD3+ cell and CD4+ cell was found amongthe three groups.The percentage ofthe CD8+ cell in the group A was significantlyhigher than that in the group B(P=0.001) and group C(P0.01).And CD4+/CD8+ ratio in the group C was also higher than that in the group A (P=0.001) and group B(P=0.01).There was significant difference in the percentages of the S100+ cell between group A and the group B(P=0.015).Conclusions Abnormal cellular immunity of spleen is found in patients with ITP.There isclose relationship between the hematological outcomes of splenectomy and the abnormal cellular immunity of the spleen.
出处 《中华普通外科学文献(电子版)》 2010年第4期57-60,共4页 Chinese Archives of General Surgery(Electronic Edition)
基金 广东省科技计划项目资助(2008B080703033) 广东省自然科学基金项目(9151008901000061)
关键词 脾切除术 免疫性血小板减少性紫癜 细胞免疫 Splenectomy Immune thrombocytopenic purpura Cellular immune
  • 相关文献

参考文献15

  • 1郑朝旭,谭敏,陈流华,余俊峰,林伟斌,吴志棉.腹腔镜脾切除术治疗不同类型的免疫性血小板减少性紫癜[J].中山大学学报(医学科学版),2009,30(2):191-194. 被引量:6
  • 2Kojouri K,Vesely SK,Terrell DR,et al.Splenectomy for adult patients with idiopathic thrombocytopenic purpuraia systematic review to assess long-term platelet count responses,prediction of response,and surgical complications.Blood,2004,104(9):2623-2634.
  • 3Frederiksen H,Schmidt K.The incidence of idiopathic thrombocytopenic purpura in adults increases with age.Blood,1999,94(3):909-913.
  • 4Cines DB,McMillan R.Management of adult idiopathic thrombocytopenic purpura.Anno Rev Med,2005,56:425-442.
  • 5Coopamah MD.Garvey MB,Freedman J.et al.Cellular immune mechanisms in autoimmune thrombocytopenic purpura:An update.Transfus Med Rev,2003,17(1):69-80.
  • 6Semple JW.ITP:a new regulatory issue!.Eur J Haematol,2007,79 (4):279-280.
  • 7Kuwana M.Okazaki Y,Kaburaki J.et al.Spleen is a primary site for activation of platelet-reactive T and B cells in patients with immune thrombocytopenic purpura.J Immunol,2002,168(7):3675-3682.
  • 8Wang T.Zhao H.Ren H.et al.Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura.Haematologica,2005,90 (7):914-923.
  • 9Yoshimura C,Nomura S,Nagahama M,et al.Plasma-soluble Fas (AFO -1,CD95) and soluble Fas ligand in immunethromoocytopenic purpura.Eur J Haematol,2000,64(4):219-224.
  • 10Haqqqvist B.Hultman P.Effects of deviating the TH2-response in murine mercury-induced autoimmunity towards a TH1-response.Clin Exp Immunol,2003,134(2):202-209.

二级参考文献20

  • 1Delaitre B, Maignien B. Laparoscopic splenectomytechnical aspects [ J ]. Surg Endosc, 1992,6 (6) : 305- 308.
  • 2Kang CM, Lee JG, Kim KS, et al. Long-term follow- up of laparoscopic splenectomy in patients with immune thrombocytopenic purpura [J]. J Korean Med Sci, 2007,22 (3) : 420-424.
  • 3Szold A, Sagi B, Merhav A, et al. Optimizing laparoscopic splenectomy : Technical details and experience in 59 patients [J]. Surg Endosc, 1998,12 (8) : 1078-1081.
  • 4Wani NA, Parray FQ. Therapeutic spleneetomy in immune thrombocytopenic purpura [J]. World J Surg, 2000,24( 1 ) : 92-94.
  • 5Cines DB, Blanchette VS. Immune thrombocytopenic purpura [J]. New Engl J Med, 2002,346(13):995- 1008.
  • 6Kojouri K, Vesely SK, Terrell DR, et al. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications [J]. Blood, 2004,104(9) : 2623-2634.
  • 7Cordera F, Long KH, Nagorney DM, et al. Open versus laparoscopic splenectomy for idiopathic thrombocytopenic purpura: clinical and economic analysis [J]. Surgery, 2003,134( 1 ) :45-52.
  • 8Keidar A, Sagi B, Szold A. Laparoscopie spleneetomy for immune thrombocytopenic purpura in patients with severe refractory thrombocytopenia [J]. Pathophysiol Haemost Thromb, 2003,33 (2) : 116-119.
  • 9Ojima H, Kato T, Araki K, et al. Factors predicting long-term responses to splenectomy in patients with idiopathic thrombocytopenic purpura [J]. World J Surg, 2006,30(4) : 553-559.
  • 10Semple JW. T cell and cytokine abnormalities in patients with autoimmune thrombocytopenic purpura[J]. Transfus Apheresis Sci, 2003, 28: 237-242.

共引文献39

同被引文献49

  • 1杨宇飞,周霭祥,麻柔.免疫性血小板减少性紫癜动物模型的建立[J].中华血液学杂志,1994,15(3):160-161. 被引量:88
  • 2许勇钢,杨晓红,王洪志,麻柔.金薯叶止血合剂对ITP模型动物的治疗作用[J].中国中医基础医学杂志,2006,12(9):674-676. 被引量:13
  • 3Toltl LJ, Arnold DM. Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters[J]. Br J Haematol, 2011, 152(1) :52 -60.
  • 4Karakantza M, MouzakiA, Theodompoulou M, et al. Th1 and Th2 cytokines in a patient with Evans' syndrome and profound lymphopenia [J]. Br J Haematol, 2000, 110 (4) :968 -970.
  • 5British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy [ J ]. Br J Haematol, 2003,120 (4) :574 - 596.
  • 6Panitsas FP, Theodoropoulou M, Kouraklis A, et al. Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type - 1 polarized immune response[J]. Blood, 2004, 103(7) :2645 -2647.
  • 7Guo C, Chu X, Shi Y, et al. Correction of Th1 - dominant cytokine profiles by high - dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura [J]. J Clin Immunol, 2007, 27(6) :557 -562.
  • 8Andersson PO, StockelbergD, JacobssonS, et al. A transforming growth factor - β1 - mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpura [J]. Ann Hematol, 2000, 79(9) :507 -513.
  • 9Webber NP, Mascarenhas JO, Crow MK, et al. Functional properties of lymphocytes in idiopathic thrombocytopenic purpura[ J ]. Hum Immunol, 2001, 62 (12) : 1346 - 1355.
  • 10Gorelik L, Flavell RA. Abrogation of TGF - β signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease[J]. Immunity, 2000, 12(2) :171 - 181.

引证文献5

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部